‘The combination of the drug and psychotherapy is critical. What will be interesting to see is how the healthcare infrastructure reacts to that...'

“The logic behind setting up Beckley Psytech was that there’s this body of evidence that’s been generated in an academic setting, in early stage, proof of concept settings.

The Psychedelics as Medicine Report: Third Edition provides unparalleled consumer insights and market intelligence from experts and industry leaders, helping investors cut through the noise and identify real opportunities.

Q&A with Beckley Psytech CEO Cosmo Feilding Mellen

Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding. Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to opening the doors to scientific research has been pivotal and widely acknowledged.